Thank you for giving us early information about the upcoming NFRF Transformation competition and requesting feedback. I have the following suggestions on the framework:
Having both “high risk” and “feasibility” be review criteria seems contradictory and is incredibly confusing for both applicants and reviewers. If by “high risk”, you actually …
CIHR has maintained a focus on four research priorities (i.e., Patient Improvements, Indigenous Health, Prevention, and Chronic Illness) to guide its strategic investments over the last ten years. What advice do you have …
How can publicly assisted postsecondary education institutions and technology transfer offices better facilitate the creation and the commercialization of ideas and technologies?
Universities and colleges exist, in part, to create and disseminate a public body of knowledge accessible to all. Today’s science and engineering research relies on the free …
Does this guidance address sufficiently the important ethical concerns in establishing meaningful research partnerships between patients and researchers? Are the reflections helpful?
The guidance is missing a major component: guidance on …
Thank you for the opportunity to comment on the Tri-Agency Research Data Management Policy. I welcome this timely effort to improve data management in Canadian research. Comments in individual areas you requested follow.
Impact of the suggested requirements (in section 3) for researchers, research communities and …
I am one of your constituents in Toronto and write to you with my strong support for the Genetic Non-Discrimination Bill, S-201.
I run a genomics research lab at Princess Margaret Cancer Centre. To prevent and better treat genomic diseases like cancer and congenital childhood diseases, we need …
I am one of your constituents in Toronto and write to you about my concern on bill C-23, which expands the power of U.S. preclearance officers in Canada.
In the past few weeks, the Trump administration has proven its desire and ability to abuse its border control …